Beth S. Friedman

723 total citations
16 papers, 558 citations indexed

About

Beth S. Friedman is a scholar working on Physiology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Beth S. Friedman has authored 16 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 6 papers in Immunology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Beth S. Friedman's work include Mast cells and histamine (6 papers), Asthma and respiratory diseases (6 papers) and Urticaria and Related Conditions (4 papers). Beth S. Friedman is often cited by papers focused on Mast cells and histamine (6 papers), Asthma and respiratory diseases (6 papers) and Urticaria and Related Conditions (4 papers). Beth S. Friedman collaborates with scholars based in United States, Belgium and Netherlands. Beth S. Friedman's co-authors include Dean D. Metcalfe, Peter J. Sterk, Jeffry B. Lawrence, Harvey R. Gralnick, Vernon M. Chinchilli, William D. Travis, A. Buntinx, Wesley Tanaka, Sumiko Shingo and Reynold Spector and has published in prestigious journals such as The American Journal of Medicine, Journal of Allergy and Clinical Immunology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Beth S. Friedman

16 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beth S. Friedman United States	10	262	235	190	167	145	16	558
Saula Ravasi Italy	13	270 1.0×	125 0.5×	90 0.5×	14 0.1×	50 0.3×	16	583
H. Yamaya Japan	10	113 0.4×	70 0.3×	56 0.3×	34 0.2×	79 0.5×	20	332
Masakiyo Yatomi Japan	10	100 0.4×	64 0.3×	147 0.8×	40 0.2×	17 0.1×	33	422
Dong‐Hyeon Suh South Korea	9	92 0.4×	114 0.5×	45 0.2×	70 0.4×	17 0.1×	9	384
Mizuo Miyazaki Japan	15	84 0.3×	401 1.7×	21 0.1×	31 0.2×	56 0.4×	16	715
Alysia Kern Lovgren United States	6	69 0.3×	39 0.2×	137 0.7×	18 0.1×	13 0.1×	6	501
Melker Göransson Sweden	12	173 0.7×	70 0.3×	144 0.8×	25 0.1×	10 0.1×	14	673
Kiyoto Sakata Japan	12	114 0.4×	130 0.6×	14 0.1×	35 0.2×	22 0.2×	24	392
Kumiko Goto Japan	10	136 0.5×	83 0.4×	59 0.3×	7 0.0×	20 0.1×	13	373
John Paddock United States	8	33 0.1×	149 0.6×	66 0.3×	27 0.2×	27 0.2×	9	453

Countries citing papers authored by Beth S. Friedman

Since Specialization

Citations

This map shows the geographic impact of Beth S. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth S. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth S. Friedman more than expected).

Fields of papers citing papers by Beth S. Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth S. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth S. Friedman. The network helps show where Beth S. Friedman may publish in the future.

Co-authorship network of co-authors of Beth S. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Beth S. Friedman. A scholar is included among the top collaborators of Beth S. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth S. Friedman. Beth S. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wolfe, Jeremy D., et al.. (2005). Formoterol 24 μg provides effective bronchodilation and is well tolerated in patients with persistent stable asthma. Journal of Allergy and Clinical Immunology. 115(2). S150–S150. 1 indexed citations

Diamant, Zuzana, Mieke Timmers, H. van der Veen, et al.. (1995). The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. Journal of Allergy and Clinical Immunology. 95(1). 42–51. 118 indexed citations

Hillingsø, Jens, Jens Kjeldsen, Laurits S. Laursen, et al.. (1995). Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis. Clinical Pharmacology & Therapeutics. 57(3). 335–341. 17 indexed citations

Friedman, Beth S., Anne Van Hecken, Inge De Lepeleire, et al.. (1994). Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase—activating protein inhibitor. Clinical Pharmacology & Therapeutics. 56(1). 22–30. 16 indexed citations

Depré, Marleen, Beth S. Friedman, Wesley Tanaka, et al.. (1993). Biochemical activity, pharmacokinetics, and tolerability of MK-886, a leukotriene biosynthesis inhibitor, in humans. Clinical Pharmacology & Therapeutics. 53(5). 602–607. 18 indexed citations

Friedman, Beth S., A. Buntinx, Wesley Tanaka, et al.. (1993). Oral Leukotriene Inhibitor (MK-886) Blocks Allergen-induced Airway Responses. American Review of Respiratory Disease. 147(4). 839–844. 126 indexed citations

Zhang, Ji, Sumiko Shingo, Theodore F. Reiss, Beth S. Friedman, & Thomas Capizzi. (1993). P44 Statistical issues in the design and analysis of clinical trials evaluating therapy for chronic asthma. Controlled Clinical Trials. 14(5). 445–445. 2 indexed citations

Lammers, JW, Paul Van Daele, Marc Decramer, et al.. (1992). Bronchodilator properties of an inhaled leukotriene D4 antagonist (verlukast—MK-0679) in asthmatic patients. Pulmonary Pharmacology. 5(2). 121–125. 18 indexed citations

Lawrence, Jeffry B., Beth S. Friedman, William D. Travis, et al.. (1991). Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis. The American Journal of Medicine. 91(6). 612–624. 131 indexed citations

10.

Friedman, Beth S. & Dean D. Metcalfe. (1991). Effects of tixocortol pivalate on gastrointestinal disease in systemic mastocytosis: a preliminary study. Clinical & Experimental Allergy. 21(2). 183–188. 10 indexed citations

11.

Friedman, Beth S., Gail Darling, James Norton, Leigh S. Hamby, & Dean D. Metcalfe. (1990). Splenectomy in the management of systemic mast cell disease.. PubMed. 107(1). 94–100. 31 indexed citations

12.

Friedman, Beth S. & Philip D. Lumb. (1990). Prevention and Management of Metabolic Alkalosis. Journal of Intensive Care Medicine. 5(1_suppl). S22–S27. 2 indexed citations

13.

Friedman, Beth S. & Dean D. Metcalfe. (1989). Mastocytosis.. PubMed. 297. 163–73. 1 indexed citations

14.

Friedman, Beth S., et al.. (1989). Analysis of plasma histamine levels in patients with mast cell disorders. The American Journal of Medicine. 87(6). 649–654. 61 indexed citations

15.

Friedman, Beth S., et al.. (1989). Analysis of plasma histamine levels in patients with mast cell disorders. The American Journal of Medicine. 87. 649–654. 1 indexed citations

16.

Schiffman, Philip L., Beth S. Friedman, Teodoro V. Santiago, & Norman H. Edelman. (1984). Effect of naloxone on ventilatory control in parents of victims of sudden infant death syndrome.. PubMed. 130(6). 964–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact